{"id":750184,"date":"2023-04-24T07:06:52","date_gmt":"2023-04-24T11:06:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/"},"modified":"2023-04-24T07:06:52","modified_gmt":"2023-04-24T11:06:52","slug":"aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/","title":{"rendered":"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO and TORONTO, April  24, 2023  (GLOBE NEWSWIRE) &#8212; Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2023, on Monday, May 8, 2023, after the close of the market, and provide a corporate update.<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <em>Conference Call &amp; Webcast:<\/em><br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:30%;width:30%;min-width:30%\">\n            <strong>Date:<\/strong>\n          <\/td>\n<td style=\"max-width:70%;width:70%;min-width:70%;text-align: left;vertical-align: middle\">Monday, May 8, 2023<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Time:<\/strong>\n          <\/td>\n<td style=\"text-align: left;vertical-align: middle\">5:00 PM ET<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Audio Webcast Only:<\/strong>\n          <\/td>\n<td style=\"text-align: left;vertical-align: middle\">\n            <strong><br \/>\n              <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/gcpj4mnf\" rel=\"nofollow noopener\" target=\"_blank\">link<\/a><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Q&amp;A Participant Registration Link*:<\/strong>\n          <\/td>\n<td style=\"text-align: left;vertical-align: middle\">\n            <strong><br \/>\n              <a href=\"https:\/\/register.vevent.com\/register\/BI0c4e6d84e0b848f79be80dfa78e465bd\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\">\n            <strong>(<\/strong><br \/>\n            <a href=\"https:\/\/register.vevent.com\/register\/BI0c4e6d84e0b848f79be80dfa78e465bd\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n              <strong>https:\/\/register.vevent.com\/register\/BI0c4e6d84e0b848f79be80dfa78e465bd<\/strong><br \/>\n            <\/a><br \/>\n            <strong>)<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">*Analysts interested in participating in the question-and-answer session will pre-register for the event from the participant registration link above to receive the dial-in numbers and a unique PIN, which are required to access the conference call. They also will have the option to take advantage of a Call Me button and the system will automatically dial out to connect to the Q&amp;A session.<\/p>\n<p align=\"justify\">The audio webcast also can be accessed through a link on the Investor Relations section of Aptose\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_ne2mgV3obPGoBZj_IZfMqh8pz1967QopPNWmDnzH7YAeGvAC8loEnxLSAXDGdaC1XpWQe5j1HHdqmanXgS_39foQZGS_d_H9xQX6z2nJebUT6-0uwhkpWvABMy-Qwfu\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. A replay of the webcast will be available on the company\u2019s website for 30 days.<\/p>\n<p align=\"justify\">The press release, the financial statements and the management\u2019s discussion and analysis for the quarter ended March 31, 2023 will be available on SEDAR at www.sedar.com and EDGAR at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QWB_8GLM_iPqRH-xlL1fGJc8Rw4rAw3Fb1vU4LKfUZwMFdpymKidmZLua3sVA4Jc69sPNWnQq0PXFp5oD1P4FK067vpa7nOD6qWWomIlZ4A=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.sec.gov\/edgar.shtml<\/u>.<\/a><\/p>\n<p align=\"justify\">\n        <strong>About Aptose<\/strong>\n      <\/p>\n<p align=\"justify\">Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company&#8217;s small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. The Company has two clinical-stage oral kinase inhibitors under development for hematologic malignancies: tuspetinib (HM43239), an oral, myeloid kinase inhibitor being studied as monotherapy and in combination therapy in the APTIVATE international Phase 1\/2 expansion trial in patients with relapsed or refractory acute myeloid leukemia (AML); and luxeptinib (CG-806), an oral, dual lymphoid and myeloid kinase inhibitor in Phase 1 a\/b stage development for the treatment of patients with relapsed or refractory hematologic malignancies. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1LWyF62khHpV70zlgd07rNTZESWM57PABq_mgM8BChgriLYK2kDpdm9THJPw_Yq_C_RuLmwYnfvujswDAuko8w==\" rel=\"nofollow noopener\" target=\"_blank\">www.aptose.com<\/a>.<\/p>\n<p align=\"justify\">For further information, please contact:<\/p>\n<table style=\"border-collapse: collapse;width:80%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%\">\n            <strong>Aptose Biosciences Inc.<\/strong>\n          <\/td>\n<td style=\"max-width:50%;width:50%;min-width:50%\">\n            <strong>LifeSci Advisors, LLC<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Susan Pietropaolo<\/td>\n<td>Dan Ferry, Managing Director<\/td>\n<\/tr>\n<tr>\n<td>Corporate Communications &amp; Investor Relations<\/td>\n<td>617-430-7576<\/td>\n<\/tr>\n<tr>\n<td>201-923-2049<\/td>\n<td>Daniel@LifeSciAdvisors.com<\/td>\n<\/tr>\n<tr>\n<td>spietropaolo@aptose.com<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTRkYmQwMjUtNzJlNi00MDJmLWFlZDAtM2I2NTc5MjY1Mjc5LTEwMzkyNTM=\/tiny\/Aptose-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO and TORONTO, April 24, 2023 (GLOBE NEWSWIRE) &#8212; Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2023, on Monday, May 8, 2023, after the close of the market, and provide a corporate update. Conference Call &amp; Webcast: Date: Monday, May 8, 2023 Time: 5:00 PM ET Audio Webcast Only: link Q&amp;A Participant Registration Link*: here ( https:\/\/register.vevent.com\/register\/BI0c4e6d84e0b848f79be80dfa78e465bd ) *Analysts interested in participating in the question-and-answer session will pre-register for the event from the participant registration link above to receive the dial-in numbers and a unique PIN, which are required to access the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-750184","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO and TORONTO, April 24, 2023 (GLOBE NEWSWIRE) &#8212; Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2023, on Monday, May 8, 2023, after the close of the market, and provide a corporate update. Conference Call &amp; Webcast: Date: Monday, May 8, 2023 Time: 5:00 PM ET Audio Webcast Only: link Q&amp;A Participant Registration Link*: here ( https:\/\/register.vevent.com\/register\/BI0c4e6d84e0b848f79be80dfa78e465bd ) *Analysts interested in participating in the question-and-answer session will pre-register for the event from the participant registration link above to receive the dial-in numbers and a unique PIN, which are required to access the &hellip; Continue reading &quot;Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T11:06:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023\",\"datePublished\":\"2023-04-24T11:06:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/\"},\"wordCount\":409,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/\",\"name\":\"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=\",\"datePublished\":\"2023-04-24T11:06:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/","og_locale":"en_US","og_type":"article","og_title":"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 - Market Newsdesk","og_description":"SAN DIEGO and TORONTO, April 24, 2023 (GLOBE NEWSWIRE) &#8212; Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended March 31, 2023, on Monday, May 8, 2023, after the close of the market, and provide a corporate update. Conference Call &amp; Webcast: Date: Monday, May 8, 2023 Time: 5:00 PM ET Audio Webcast Only: link Q&amp;A Participant Registration Link*: here ( https:\/\/register.vevent.com\/register\/BI0c4e6d84e0b848f79be80dfa78e465bd ) *Analysts interested in participating in the question-and-answer session will pre-register for the event from the participant registration link above to receive the dial-in numbers and a unique PIN, which are required to access the &hellip; Continue reading \"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-24T11:06:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023","datePublished":"2023-04-24T11:06:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/"},"wordCount":409,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/","name":"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=","datePublished":"2023-04-24T11:06:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMzAwNSM1NTQwMjA1IzIwMjcyODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptose-to-report-first-quarter-2023-financial-results-and-hold-conference-call-on-monday-may-8-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/750184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=750184"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/750184\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=750184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=750184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=750184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}